ABOS
Price
$1.09
Change
+$0.07 (+6.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
59.49M
26 days until earnings call
ALEC
Price
$1.17
Change
+$0.01 (+0.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
109.99M
7 days until earnings call
Ad is loading...

ABOS vs ALEC

Header iconABOS vs ALEC Comparison
Open Charts ABOS vs ALECBanner chart's image
Acumen Pharmaceuticals
Price$1.09
Change+$0.07 (+6.86%)
Volume$8.04K
Capitalization59.49M
Alector
Price$1.17
Change+$0.01 (+0.86%)
Volume$4.54K
Capitalization109.99M
ABOS vs ALEC Comparison Chart
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. ALEC commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and ALEC is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (ABOS: $1.02 vs. ALEC: $1.18)
Brand notoriety: ABOS and ALEC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 149% vs. ALEC: 220%
Market capitalization -- ABOS: $59.49M vs. ALEC: $109.99M
ABOS [@Biotechnology] is valued at $59.49M. ALEC’s [@Biotechnology] market capitalization is $109.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileALEC’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • ALEC’s FA Score: 0 green, 5 red.
According to our system of comparison, ALEC is a better buy in the long-term than ABOS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 5 TA indicator(s) are bullish while ALEC’s TA Score has 4 bullish TA indicator(s).

  • ABOS’s TA Score: 5 bullish, 2 bearish.
  • ALEC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than ALEC.

Price Growth

ABOS (@Biotechnology) experienced а +4.08% price change this week, while ALEC (@Biotechnology) price change was +20.62% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.11%. For the same industry, the average monthly price growth was -6.02%, and the average quarterly price growth was -12.56%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

ALEC is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+7.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALEC($110M) has a higher market cap than ABOS($59.5M). ALEC YTD gains are higher at: -37.566 vs. ABOS (-40.698). ABOS has higher annual earnings (EBITDA): -77.89M vs. ALEC (-136.16M). ALEC has more cash in the bank: 413M vs. ABOS (200M). ABOS has less debt than ALEC: ABOS (28.5M) vs ALEC (42.5M). ALEC has higher revenues than ABOS: ALEC (101M) vs ABOS (0).
ABOSALECABOS / ALEC
Capitalization59.5M110M54%
EBITDA-77.89M-136.16M57%
Gain YTD-40.698-37.566108%
P/E RatioN/AN/A-
Revenue0101M-
Total Cash200M413M48%
Total Debt28.5M42.5M67%
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABOSALEC
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
84%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
MACD
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
80%
Declines
ODDS (%)
Bearish Trend 8 days ago
88%
Bearish Trend 8 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
87%
Aroon
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
84%
View a ticker or compare two or three
Ad is loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHHVF313.105.87
+1.91%
Roche Holding Ltd
ELUXY14.970.19
+1.29%
AB Electrolux
DNBBY25.070.12
+0.48%
DNB ASA
ANGPY6.16-0.26
-4.05%
Anglo American Platinum Ltd.
NUMIF0.03-0.01
-16.67%
Numinus Wellness Inc.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with ATOS. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
+3.86%
ATOS - ABOS
54%
Loosely correlated
+11.25%
FHTX - ABOS
50%
Loosely correlated
+10.38%
BEAM - ABOS
48%
Loosely correlated
+3.87%
GBIO - ABOS
48%
Loosely correlated
+9.99%
CRBU - ABOS
47%
Loosely correlated
+0.79%
More

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+6.31%
RGNX - ALEC
48%
Loosely correlated
+13.43%
BEAM - ALEC
48%
Loosely correlated
+3.87%
DNLI - ALEC
47%
Loosely correlated
+1.85%
ABOS - ALEC
47%
Loosely correlated
+3.86%
RCKT - ALEC
45%
Loosely correlated
+2.44%
More